Lysophosphatidic Acid-Induced Effects in Human Colon Carcinoma DLD1 Cells Are Partially Dependent on Transactivation of Epidermal Growth Factor Receptor

Journal of Surgical Research

Volumn 132, Issue 1, 2006, Pages 56-61

  Mori, Ken ^a   Kitayama, Joji ^a   Shida, Dai ^a   Yamashita, Hiroharu ^a   Watanabe, Toshiaki ^a   Nagawa, Hirokazu ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

colon cancer cells; epidermal growth factor; lysophosphatidic acid (LPA); migration; transactivation

Indexed keywords

4 (3 CHLOROANILINO) 6,7 DIMETHOXYQUINAZOLINE; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR; ILOMASTAT; INTERLEUKIN 8; LYSOPHOSPHATIDIC ACID; MATRIX METALLOPROTEINASE INHIBITOR;

ARTICLE; CANCER CELL; CELL MIGRATION; COLON CARCINOMA; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TUMOR GROWTH;

CELL LINE, TUMOR; CHEMOTAXIS; COLONIC NEOPLASMS; DIPEPTIDES; ENZYME INHIBITORS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; INTERLEUKIN-8; LYSOPHOSPHOLIPIDS; PHOSPHORYLATION; PHOSPHOTYROSINE; PROTEASE INHIBITORS; RECEPTOR, EPIDERMAL GROWTH FACTOR; TRANS-ACTIVATION (GENETICS); TYRPHOSTINS;

EID: 33645986145     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2005.07.040     Document Type: Article

References (43)

1. Moolenaar W.H. Lysophosphatidic acid, a multifunctional phospholipid messenger. J. Biol. Chem. 270 (1995) 12949
2. Goetzl E.J., and An S. Diversity of cellular receptors and functions for the lysophospholipid growth factors lysophosphatidic acid and sphingosine 1-phosphate. FASEB. J. 12 (1998) 1589
3. Mills G.B., and Moolenaar W.H. The emerging role of lysophosphatidic acid in cancer. Nat. Rev. Cancer 3 (2003) 582
4. Umezu-Goto M., Kishi Y., Taira A., et al. Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production. J. Cell. Biol. 158 (2002) 227
5. Kitayama J., Shida D., Sako A., et al. Over-expression of lysophosphatidic acid receptor-2 in human invasive ductal carcinoma. Breast Cancer Res. 6 (2004) R640
6. Shida D., Kitayama J., Yamaguchi H., et al. Lysophosphatidic acid (LPA) enhances the metastatic potential of human colon carcinoma DLD1 cells through LPA1. Cancer Res. 63 (2003) 1706
7. Shida D., Watanabe T., Aoki J., et al. Aberrant expression of lysophosphatidic acid (LPA) receptors in human colorectal cancer. Lab. Invest. 84 (2004) 1352
8. Ito Y., Higashiyama S., Takeda T., Okada M., and Matsuura N. Bimodal expression of heparin-binding EGF-like growth factor in colonic neoplasms. Anticancer Res. 21 (2001) 1391
9. Kopp R., Rothbauer E., Ruge M., et al. Clinical implications of the EGF receptor/ligand system for tumor progression and survival in gastrointestinal carcinomas. Evidence for new therapeutic options. Recent Results Cancer Res. 162 (2003) 115
10. Gschwind A., Zwick E., Prenzel N., Leserer M., and Ullrich A. Cell communication networks. Epidermal growth factor receptor transactivation as the paradigm for interreceptor signal transmission. Oncogene 20 (2001) 1594
11. Fischer O.M., Hart S., Gschwind A., and Ullrich A. EGFR signal transactivation in cancer cells. Biochem. Soc. Trans. 31 (2003) 1203
12. Daub H., Weiss F.U., Wallasch C., and Ullrich A. Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptors. Nature 379 (1996) 557
13. Daub H., Wallasch C., Lankenau A., Herrlich A., and Ullrich A. Signal characteristics of G protein-transactivated EGF receptor. EMBO. J. 16 (1997) 7032
14. Moolenaar W.H. Bioactive lysophospholipids and their G protein-coupled receptors. Exp. Cell Res. 253 (1999) 230
15. Shida D., Kitayama J., Yamaguchi H., et al. Dual mode regulation of migration by lysophosphatidic acid in human gastric cancer cells. Exp. Cell Res. 301 168- (2004) 178
16. Shida D., Kitayama J., Yamaguchi H., et al. Sphingosine 1-phosphate transactivates c-Met as well as epidermal growth factor receptor (EGFR) in human gastric cancer cells. FEBS Lett. 577 (2004) 333
17. Endo A., Nagashima K., Kurose H., Mochizuki S., Matsuda M., and Mochizuki N. Sphingosine 1-phosphate induces membrane ruffling and increases motility of human umbilical vein endothelial cells via vascular endothelial growth factor receptor and CrkII. J. Biol. Chem. 277 (2002) 23747
18. Kim J.H., Song W.K., and Chun J.S. Sphingosine 1-phosphate activates Erk-1/-2 by transactivating epidermal growth factor receptor in rat-2 cells. IUBMB Life 50 (2000) 119
19. Tanimoto T., Lungu A.O., and Berk B.C. Sphingosine 1-phosphate transactivates the platelet-derived growth factor beta receptor and epidermal growth factor receptor in vascular smooth muscle cells. Circ. Res. 94 (2004) 1050
20. Ueda T., Shimada E., and Urakawa T. Serum levels of cytokines in patients with colorectal cancer. Possible involvement of interleukin-6 and interleukin-8 in hematogenous metastasis. J. Gastroenterol. 29 (1994) 423
21. Allgayer H., Babic R., Gruetzner K.U., Tarabichi A., Schildberg F.W., and Heiss M.M. c-erbB-2 is of independent prognostic relevance in gastric cancer and is associated with the expression of tumor-associated protease systems. J. Clin. Oncol. 18 (2000) 2201
22. Khorana A.A., Ryan C.K., Cox C., Eberly S., and Sahasrabudhe D.M. Vascular endothelial growth factor. CD68, and epidermal growth factor receptor expression and survival in patients with Stage II and Stage III colon carcinoma: a role for the host response in prognosis. Cancer 97 (2003) 960
23. Ghaderi A., Vasei M., Maleck-Hosseini S.A., et al. The expression of c-erbB-1 and c-erbB-2 in Iranian patients with gastric carcinoma. Pathol. Oncol. Res. 8 (2002) 252
24. Fujita T., Miyamoto S., Onoyama I., Sonoda K., Mekada E., and Nakano H. Expression of lysophosphatidic acid receptors and vascular endothelial growth factor mediating lysophosphatidic acid in the development of human ovarian cancer. Cancer Lett. 192 (2003) 161
25. Di Renzo M.F., Olivero M., Giacomini A., et al. Overexpression and amplification of the met/HGF receptor gene during the progression of colorectal cancer. Clin. Cancer Res. 1 (1995) 147
26. Prenzel N., Zwick E., Daub H., et al. EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF. Nature 402 (1999) 884
27. Zwick E., Hackel P.O., Prenzel N., and Ullrich A. The EGF receptor as central transducer of heterologous signalling systems. Trends Pharmacol. Sci. 20 (1999) 408
28. Gschwind A., Prenzel N., and Ullrich A. Lysophosphatidic acid-induced squamous cell carcinoma cell proliferation and motility involves epidermal growth factor receptor signal transactivation. Cancer Res. 62 (2002) 6329
29. Kue P.F., Taub J.S., Harrington L.B., Polakiewicz R.D., Ullrich A., and Daaka Y. Lysophosphatidic acid-regulated mitogenic ERK signaling in androgen-insensitive prostate cancer PC-3 cells. Int. J. Cancer 102 (2002) 572
30. Schafer B., Gschwind A., and Ullrich A. Multiple G-protein-coupled receptor signals converge on the epidermal growth factor receptor to promote migration and invasion. Oncogene 23 (2004) 991
31. Braun A.H., Achterrath W., Wilke H., Vanhoefer U., Harstrick A., and Preusser P. New systemic frontline treatment for metastatic colorectal carcinoma. Cancer 100 (2004) 1558
32. Folprecht G., and Kohne C.H. The role of new agents in the treatment of colorectal cancer. Oncology 66 (2004) 1
33. Harris M. Monoclonal antibodies as therapeutic agents for cancer. Lancet Oncol. 5 (2004) 292
34. Veronese M.L., and O'Dwyer P.J. Monoclonal antibodies in the treatment of colorectal cancer. Eur. J. Cancer 40 (2004) 1292
35. Nicholson R.I., Gee J.M., and Harper M.E. EGFR and cancer prognosis. Eur. J. Cancer 37 Suppl 4 (2001) S9
36. Mayer A., Takimoto M., Fritz E., Schellander G., Kofler K., and Ludwig H. The prognostic significance of proliferating cell nuclear antigen, epidermal growth factor receptor, and mdr gene expression in colorectal cancer. Cancer 71 (1993) 2454
37. Kim E.S., Khuri F.R., and Herbst R.S. Epidermal growth factor receptor biology (IMC-C225). Curr. Opin. Oncol. 13 (2001) 506
38. Ciardiello F., and Tortora G. A novel approach in the treatment of cancer. Targeting the epidermal growth factor receptor. Clin. Cancer Res. 7 (2001) 2958
39. Pai R., Nakamura T., Moon W.S., and Tarnawski A.S. Prostaglandins promote colon cancer cell invasion; signaling by cross-talk between two distinct growth factor receptors. FASEB J. 17 (2003) 1640
40. Cheng K., Zimniak P., and Raufman J.P. Transactivation of the epidermal growth factor receptor mediates cholinergic agonist-induced proliferation of H508 human colon cancer cells. Cancer Res. 63 (2003) 6744
41. Ukegawa J.I., Takeuchi Y., Kusayanagi S., and Mitamura K. Growth-promoting effect of muscarinic acetylcholine receptors in colon cancer cells. J. Cancer Res. Clin. Oncol. 129 (2003) 272
42. Darmoul D., Gratio V., Devaud H., and Laburthe M. Protease-activated receptor 2 in colon cancer. Trypsin-induced MAPK phosphorylation and cell proliferation are mediated by epidermal growth factor receptor transactivation. J. Biol. Chem. 279 (2004) 20927
43. Itoh Y., Joh T., Tanida S., et al. IL-8 promotes cell proliferation and migration through metalloproteinase-cleavage proHB-EGF in human colon carcinoma cells. Cytokine 29 (2005) 275